Thresholds for carcinogens: A review of the relevant science and its implications for regulatory policy

What Risk?

Volumn , Issue , 1997, Pages 3-36

  Wilson, James D ^a  

^a Center for Risk Management   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84940868577     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-052100-8.50008-7     Document Type: Chapter

References (61)

1. J.L. Alvarez F. Seiler Health Physics 1996 (in press).
2. B.N. Ames R.L. Saul Oxidative DNA damage as related to cancer and ageing In Genetic Toxicology of Environmental Chemicals . A : Basic Principles and Mechanisms of Action 1986 Alan R. Liss Inc
3. R.C. Barnard Some regulatory definitions of risk: interaction of scientific and legal principles Regulatory Toxicology and Pharmacology 11 1990 201 211
4. R.A. Bradshaw S. Prentis Oncogenes and Growth Factors 1987 Elsevier Science Publishers Amsterdam
5. D..M. Byrd L.B. Lave C. Whipple De Minimus Risk Significant risk is not the antonym of de minimus risk 1987 Plenum Publishing Company New York Also D. M. Byrd and L. B. Lave,1987. Narrowing the range: a framework for risk regulators. Issues in Science and Technology (Summer), 92-100.
6. S.M. Cohen L.B. Ellwein Proliferative and genotoxic cellular effects in 2-acteylaminofluorene bladder and liver carcinogenesis: biological modelling of the ED01 study Toxicology and Applied Pharmacology 104 1990 79 93
7. S.M. Cohen D.T. Purtillo L.B. Ellwein Pivotal role of increased cell proliferation in human carcinogenesis Modern Pathology 4 1991 371 382
8. M. Crawford R. Wilson Low-dose linearity: the rule or the exception? Human and Ecological Risk Assessment 2 1995 305 330
9. F.B. Cross D.M. Byrd III L.B. Lave Discernible risk – a proposed standard for significant risk in carcinogen regulation Administrative Law Review 43 1991 61 88
10. K.S. Crump A new method for determining allowable daily intakes Fundamental and Applied Toxicology 4 1984 854 871
11. K.S. Crump D.G. Hoel C.H. Langley R. Peto Fundamental carcinogenic processes and their implications for low dose risk assessment Cancer Research 36 1976 2973 2979
12. M. Delpla Comments on It is time to reopen the question of thresholds in radiation exposure responses by J. R. Totter Radiation Research 114 1988 578 579
13. M. Dourson D. Barnes Reference Dose (RfD): description and use in health risk assessments Regulatory Toxicology and Pharmacology 8 1988 471 486
14. L.B. Ellwein S.M. Cohen A cellular dynamics model of experimental bladder cancer: analysis of the effect of sodium saccharin in the rat Risk Analysis 8 1988 215 221
15. Environmental Protection Agency Regulation of pesticides in food: Addressing the Delaney paradox Policy statement. Fed. Reg. 53 1988 41103 41123
16. Environmental Protection Agency Proposed guidelines for carcinogen risk assessment Fed Reg. 61 1996 17960 18011 (4/23/96).
17. A.H. Fleming Testimony before the House Committee on Interstate and Foreign Commerce 1960 (86th Congress, 2nd Session) on H. R. 7624 and S. 2197, January 26, 1960.
18. R.A. Freeman J.D. Wilson A two-channel hypothesis for regulation of cellular division and differentiation J. Theor. Biol. 146 1990 303 315
19. D.W. Gaylor Preliminary estimates of the virtually safe dose for tumors obtained from the maximum tolerated dose Reg. Toxicol. Pharmacol. 9 1989 1 18
20. D.W. Gaylor Quantitative risk analysis for quantal reproductive and developmental effects Environmental Health Perspectives 79 1989 229 241
21. R.E. Greenfield L.B. Ellwein S.M. Cohen A general probabilistic model of carcinogenesis: analysis of experimental bladder cancer Carcinogenesis 5 1984 437 445
22. C. Howson P. Urbach Scientific Reasoning: The Bayesian Approach 1989 Open Court Publishing LaSalle, IL
23. I. Jones Dr Irene Jones, Lawrence Livermore Laboratory, private communication 1995
24. K.T. Kitchin J.L. Brown Dose–response relationship for rat liver DNA damage caused by 49 rodent carcinogens Toxicology 88 1994 31 49
25. A.G. Knudson Jr. Genetic predisposition to cancer H.H. Hiatt J.D. Watson J.A. Winstein Origins of Human Cancer . Book A : Incidence of Cancer in Humans. Cold Spring Harbor 1977 Cold Spring Harbor Press NY 45 52
26. A.G. Knudson Jr. Hereditary cancer, oncogenes, and anti-oncogenes Cancer Research 45 1985 1437 1443
27. A.G. Knudson Jr. JNCI Monographs 1995
28. D. Krewski D.W. Gaylor W.K. Lutz. Additivity to background and linear extrapolation S. Olin Low-Dose Extrapolation of Cancer Risks: Issues and Perspectives 1995 ILSI Press Washington, DC 105 122
29. D. Krewski D.W. Gaylor A.P. Soms M. Szyszkowicz Correlation between carcinogenic potency and the maximum tolerated dose: implications for risk assessment, in National Research Council, Issues in Risk Assessment 1993 NAS Press Washington, D C pp. 111–171
30. C.E. Land Studies of cancer and radiation dose among atomic bomb survivors. J American Medical Association 274 1995 402 407
31. L.B. Lave The Strategy of Social Regulation: Decision Frameworks for Policy 1981 The Brookings Institution Washington, DC
32. L.A. Loeb Mutator phenotype may be required for multistage carcinogenesis Cancer Research 51 1991 3075 3079
33. W.W. Lowrance Of Acceptable Risk: Science and the Determination of Safety 1976 William Kaufman, Inc. Los Altos, CA
34. B.A. Miller Gloeckler Ries L.A. Hankey B.F. Kosary SEER Cancer Statistics Review 1993 National Cancer Institute of the National Institutes of Health Bethesda, MD 1973 1990 NIH Publication No. 93-2789.
35. S.H. Moolgavkar Model for human carcinogenesis: action of environmental agents Environmental Health Perspectives 50 1983 285 291
36. S.H. Moolgavkar Carcinogenesis modelling: from molecular biology to epidemiology Annual Reviews of Public Health 7 1986 151 169
37. S.H. Moolgavkar Biologically motivated two-stage model for cancer risk assessment Toxicology Letters 43 1988 139 150
38. S.H. Moolgavkar F.T. Cross G. Luebeck G.E. Dagle A two-mutation model for radon-induced lung tumors in the rat Radiation Research 121 1990 28 37
39. S.H. Moolgavkar E.G. Luebeck Multistage carcinogenesis: population based model for colon cancer. J National Cancer Institute 84 1992 610 618
40. S.H. Moolgavkar E.G. Luebeck D. Krewski J.M. Zielinski Radon, cigarette smoke, and lung cancer: a reanalysis of the Colorado Plateau uranium miners data Epidemiology 4 1993 204 217
41. S.H. Moolgavkar A.G. Knudson Jr. Mutation and cancer: a model for human carcinogenesis. J. National Cancer Institute 66 1981 1037 1052
42. S.H. Moolgavkar D.J. Venzon Two-event models for carcinogenesis: incidence curves for childhood and adult tumors Mathematical Biosciences 47 1979 55 77
43. National Research Council Risk Assessment in the Federal Government: Managing the Process 1983 NAS Press Washington, DC
44. National Research Council Regulating Pesticides in Food: The Delaney Paradox 1987 NAS Press Washington, DC
45. National Research Council Health Effects of Exposure to Low Levels of Ionizing Radiation. (BIER V) 1990 NAS Press Washington, DC
46. National Research Council Carcinogens and Anti-carcinogens in the Human Diet 1996 NAS Press Washington, DC
47. S. Olin W. Farland C. Park L. Rhomberg Low-Dose Extrapolation of Cancer Risks: Issues and Perspectives 1995 ILSI Press Washington, DC
48. S. Preston-Martin M.C. Pike R.K. Ross P.A. Jones Increased cell division as a cause of human cancer Cancer Research 50 1990 7415 7421
49. M.J. Prival R.J. Scheuplein Regulation of carcinogens and mutagens in food in the United States M.W. Pariza H.-U. Aeschbacher J.S. Felton S. Sato Mutagens and Carcinogens in the Diet 1990 Wiley-Liss Publishers New York 307 321
50. K. Rai J. Van Ryzin A dose–response model for teratological experiments involving quantal responses Biometrics 41 1985 1 9
51. Y. Shimizu H. Kato W.J. Schull K. Mabuchi Dose-response analysis of atomic bomb survivors exposed to low-level radiation The Health Physics Newsletter 1 1993 1 5 J. L. Alvarez, Need for a new model for radiation risk assessment and management. HPS Newletter XXIII: 15-16.
52. J.L. Sebaugh J.D. Wilson M.W. Tucker W.J. Adams A study of the shape of dose–response curves for acute lethality at low response: a ‘megadaphnia’ study Risk Analysis 11 1991 633 640
53. J.G. Shaddock R.J. Feuers M.W. Chou D.A. Casciano Evidence that DNA repair may not be modified by age or chronic caloric restriction Mutation Research 301 1993 261 266
54. A.I. Shylakhter Uncertainty estimation in scientific models: Lessons from trends in physical measurements, population studies, and energy projections B.Y. Ayyub M.M. Gupta Uncertainty Modelling and Analysis: Theory and Applications 1994 477 496 Also An improved framework for uncertainty analysis: accounting for unsuspected errors, Risk Anal. 14: 441-477.
55. R.G. Thomas Radium dial painters show a practical threshold HPS Newsletter XXIII 6 1995 9 10
56. C.C. Travis T.W. McClain P.D. Birkner Diethylnitrosamine-induced hepatocarcinogenesis in rats: a theoretical study Toxicology and Applied Pharmacology 109 1991 289 304 (non-linear growth kinetics).
57. R.A. Weinberg Oncogenes and the Molecular Origins of Cancer 1989 Cold Springs Harbor Press Cold Spring Harbor, NY
58. J.D. Wilson Assessment of the low-exposure risk from carcinogens: implications of the Knudson-Moolgavkar two-critical mutation theory C.C. Travis Biologically-based Methods for Cancer Risk Assessment 1989 Plenum New York
59. J.D. Wilson A usually-unrecognized source of bias in cancer risk estimations Risk Analysis 11 1991 11 12
60. J.D. Wilson Thresholds for adverse effects from toxicants affecting hormone economy arise at the organism level H.L. Spitzer T.J. Slaga W.F. Greenlee M. McLain Receptor Mediated Biological Processes: Implications for Evaluating Carcinogens 1994 Wiley-Liss New York 223 236
61. J. Ziman Reliable Knowledge: An Exploration Of The Grounds For Belief In Science 1978 Cambridge University Press Cambridge